ArticlePloS one2026

Correction: Remdesivir-bisPropionate, a better derivative of remdesivir against SARS-CoV-2: Comparison of in vitro and in vivo PK/PD Study as well as its therapeutic potential.

Ashok Chakraborty et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.